The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are usually associated with loss of dopaminergic neurons. Loss of substantia nigra neurons and presence of Lewy body inclusions in some of the remaining neurons are the hallmark pathology seen in the final stages of the disease. Attempts to correlate Lewy body pathology to either cell death or severity of clinical symptoms, however, have not been successful. While the pathophysiology of the neurodegenerative process can hardly be explained by Lewy bodies, the clinical symptoms do indicate a degenerative process located at the presynapse resulting in a neurotransmitter deficiency. Recently it was shown that 90% or even more of alpha-synuclein aggregates in DLB cases were located at the presynapses in the form of very small deposits. In parallel, dendritic spines are retracted, whereas the presynapses are relatively preserved, suggesting a neurotransmitter deprivation. The same alpha-synuclein pathology can be demonstrated for PD. These findings give rise to the notion that not cell death but rather alpha-synuclein aggregate-related synaptic dysfunction causes the neurodegeneration. This opens new perspectives for understanding PD and DLB. If presynaptic alpha-synuclein aggregation, not neuronal loss, is the key issue of the neurodegenerative process, then PD and DLB may eventually be treatable in the future. The disease may progress via trans-synaptical spread, suggesting that stem cell transplants are of limited use. Future therapies may focus on the regeneration of synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PD is associated with four cardinal motor symptoms, including tremors, rigidity, bradykinesia, and postural instability, alongside the characteristic shuffling and stooped posture of the “Parkinsonian gait” [46].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“It could be demonstrated that the presence of symptoms may be related to the involvement of defined regions as measured by the occurrence of Lewy bodies [47–49], supporting the observations that the a-synuclein aggregation pathology spreads through the brain involving anatomical structures sequentially [13].”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“The discovery of mutations in the a-synuclein gene [77, 114, 156] and overexpression of a-synuclein [123] as being associated with Parkinson’s disease or dementia with Lewy bodies (DLB) strengthens the association between protein”
BackgroundParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 2×
“Tremor at rest, rigidity, akinesia/bradykinesia and postural instability are the four cardinal features in Parkinson’s disease [60].”
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434 · cited 1×
“The mechanism of cytotoxicity can be reproduced using designed proteins not associated with clinical diseases, but only when they were added to cultured cells in their prefibrillar state [16].”
BackgroundConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · cited 1×
“In three autopsy studies of patients who received transplants of foetal mesencephalic neurons 11–14 years earlier, Lewy body-like inclusions reacting with antibodies against a-synuclein were detected [71, 72, 86].”
BackgroundSynuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · cited 1×
“Additionally, a neuron-to-neuron spread was demonstrated using cortical neural stem cells that were implanted into a-synuclein transgenic mice [27].”
BackgroundMolecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Morphological Changes in Dendritic Spines Associated with Long-Term Synaptic Plasticity
Yuste, R., & Bonhoeffer, T. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1071 · Cited by 1,269
Huttner, W. B., Schiebler, W., Greengard, P., & De Camilli, P. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.5.1374 · Cited by 1,172
Identification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
Grazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., et al. (2006) · Science · doi:10.1126/science.1131864 · Cited by 971 · cited 1×
“For b-amyloid [102] and tau [21] seeding effects have been shown to induce the aggregation of the respective protein in transgenic animal models.”
Backgroundα-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 966
Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 938
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Kordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J. G., Mufson, E. J., Sanberg, P. R., Hauser, R. A., Smith, D. A., Nauert, G. M., Perl, D. P., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321702 · Cited by 860
George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844
Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates
Lee, H.-J., Patel, S., & Lee, S.-J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 797
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 779
McKeith, I. G. (2004) · Europe PMC (PubMed Central) · Cited by 756
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 2×
“It has been shown in brain slice preparations of C57/Bl6 mice that the depletion of the neurotransmitter dopamine leads to profound loss of dendritic spines [26].”
Backgroundthe Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698 · cited 1×
“Currently the neuropathological diagnosis of Parkinson’s disease and dementia with Lewy bodies is based on the detection and quantification of Lewy bodies [8, 9, 38, 97– 99].”
BackgroundMitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
Tu, P., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., & Lee, V. M. ‐. (1998) · Annals of Neurology · doi:10.1002/ana.410440324 · Cited by 686
α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
Wakabayashi, K., Yoshimoto, M., Tsuji, S., & Takahashi, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00407-8 · Cited by 643
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628 · cited 1×
“3 years after onset [25].”
McKeith, I. G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s347 · Cited by 625
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
Harding, A. J., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 609
Bidirectional Activity-Dependent Morphological Plasticity in Hippocampal Neurons
Nägerl, U. V., Eberhorn, N., Cambridge, S. B., & Bonhoeffer, T. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.016 · Cited by 602
Kramer, M. L., & Schulz-Schaeffer, W. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-06.2007 · Cited by 571
Self-citationEvolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
Lansbury, P. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3342 · Cited by 553
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Kontopoulos, E., Parvin, J. D., & Feany, M. B. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 537
Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524 · cited 1×
“rotenone, which causes non-detectable levels of the toxin in blood or brain, was followed by a spread of a-synuclein pathology to the dorsal motor nucleus of the vagus, the intermediolateral nucleus in the spinal cord and the substantia nigra [111].”
BackgroundLipid Rafts Mediate the Synaptic Localization of α-Synuclein
Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S.-I., Anthony, M. D., & Edwards, R. H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1594-04.2004 · Cited by 518
Wakabayashi, K., Tanji, K., Mori, F., & Takahashi, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00803.x · Cited by 516
Assembly-dependent endocytosis and clearance of extracellular a-synuclein
Lee, H.-J., Suk, J.-E., Bae, E.-J., Lee, J.-H., Paik, S. R., & Lee, S.-J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.017 · Cited by 470
Genetic prion disease: the EUROCJD experience
Kovács, G. G., Puopolo, M., Ladogana, A., Pocchiari, M., Budka, H., van Duijn, C., Collins, S. J., Boyd, A., Giulivi, A., Coulthart, M., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-0020-1 · Cited by 450
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Double-knockout mice for α- and β-synucleins: Effect on synaptic functions
Chandra, S., Fornai, F., Kwon, H.-B., Yazdani, U., Atasoy, D., Liu, X., Hammer, R. E., Battaglia, G., German, D. C., Castillo, P. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406283101 · Cited by 438
Microscopic analysis of polymerization dynamics with individual actin filaments
Fujiwara, I., Takahashi, S., Tadakuma, H., Funatsu, T., & Ishiwata, S. (2002) · Nature Cell Biology · doi:10.1038/ncb841 · Cited by 420
Alzheimer's disease and Aβ toxicity: from top to bottom
Small, D. H., Mok, S. S., & Bornstein, J. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086072 · Cited by 394
Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity
Bucciantini, M., Calloni, G., Chiti, F., Formigli, L., Nosi, D., Dobson, C. M., & Stefani, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400348200 · Cited by 369
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
Dickson, D. W., Fujishiro, H., DelleDonne, A., Menke, J., Ahmed, Z., Klos, K. J., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0345-7 · Cited by 364
Mattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 361
Ding, T. T., Lee, S.-J., Rochet, J.-C., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020139h · Cited by 356
Accumulation of Phosphorylated α-Synuclein in Aging Human Brain
Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 351
Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347 · cited 1×
“tially, it was not confirmed any earlier than the discovery that nuclear inclusions in multiple system atrophy (MSA) are composed of a-synuclein [36, 127, 138, 140, 142].”
BackgroundNuclear Localization of α-Synuclein and Its Interaction with Histones
Goers, J., Manning-Bog, A. B., McCormack, A. L., Millett, I. S., Doniach, S., Di Monte, D. A., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi0341152 · Cited by 337
Research in motion: the enigma of Parkinson's disease pathology spread
Brundin, P., Li, J.-Y., Holton, J. L., Lindvall, O., & Revesz, T. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2477 · Cited by 328
Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
Ji, H. W., Liu, Y. E., Jia, T., Wang, M., Liu, J., Xiao, G., Joseph, B. K., Rosen, C. A., & Shi, Y. (1997) · PubMed · Cited by 327
Role of α-Synuclein in Presynaptic Dopamine Recruitment
Yavich, L., Tanila, H., Vepsäläinen, S., & Jäkälä, P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2559-04.2004 · Cited by 316
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. (2005) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 315
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
Zaja-Milatovic, S., Milatovic, D., Schantz, A. M., Zhang, J., Montine, K. S., Samii, A., Deutch, A. Y., & Montine, T. J. (2005) · Neurology · doi:10.1212/01.wnl.0000150591.33787.a4 · Cited by 300 · cited 1×
“[26] and for striatal regions and the substantia nigra in human Parkinson’s disease tissues [28, 100, 113, 129, 155].”
BackgroundCortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 297
Transplanted dopaminergic neurons develop PD pathologic changes: A second case report
Kordower, J. H., Chu, Y., Hauser, R. A., Olanow, C. W., & Freeman, T. B. (2008) · Movement Disorders · doi:10.1002/mds.22369 · Cited by 287
Evidence of a breakdown of corticostriatal connections in Parkinson’s disease
Stephens, B., Mueller, A. J., Shering, A. F., Hood, S. H., Taggart, P., Arbuthnott, G. W., Bell, J. E., Kilford, L., Kingsbury, A. E., Daniel, S. E., et al. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.007 · Cited by 284
Ghetti, B., Piccardo, P., Spillantini, M. G., Ichimiya, Y., Porro, M., Perini, F., Kitamoto, T., Tateishi, J., Seiler, C., Frangione, B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.744 · Cited by 281
Kitamoto, T., Shin, R. W., Doh‐ura, K., Tomokane, N., Miyazono, M., Muramoto, T., & Tateishi, J. (1992) · PubMed · Cited by 273
Neural Activity Controls the Synaptic Accumulation of α-Synuclein
Fortin, D. L., Nemani, V. M., Voglmaier, S. M., Anthony, M. D., Ryan, T. A., & Edwards, R. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2922-05.2005 · Cited by 271
Lotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 269
Clinical phenotype of Parkinson disease dementia
Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 265
Jeffrey, M., Halliday, W. G., Bell, J., Johnston, A. R., Macleod, N. K., Ingham, C., Sayers, A. R., Brown, D. A., & Fraser, J. R. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00216.x · Cited by 262
Biochemical Characterization of the Core Structure of α-Synuclein Filaments
Miake, H., Mizusawa, H., Iwatsubo, T., & Hasegawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110551200 · Cited by 260
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms
Baglioni, S., Casamenti, F., Bucciantini, M., Luheshi, L. M., Taddei, N., Chiti, F., Dobson, C. M., & Stefani, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4809-05.2006 · Cited by 246
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) · Brain Research · doi:10.1016/0006-8993(88)90124-2 · Cited by 246 · cited 1×
“[26] and for striatal regions and the substantia nigra in human Parkinson’s disease tissues [28, 100, 113, 129, 155].”
BackgroundKahle, P. J., Neumann, M., Ozmen, L., Müller, V., Odoy, S., Okamoto, N., Jacobsen, H., Iwatsubo, T., Trojanowski, J. Q., Takahashi, H., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63072-6 · Cited by 239
Withers, G. S., George, J. M., Banker, G. A., & Clayton, D. F. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(96)00210-6 · Cited by 235
[24] Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates
Wanker, E. E., Scherzinger, E., Heiser, V., Sittler, A., Eickhoff, H., & Lehrach, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09026-6 · Cited by 233
A critical reappraisal of current staging of Lewy-related pathology in human brain
Jellinger, K. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0406-y · Cited by 230
Multiple-system atrophy: a new α-synuclein disease?
Gai, W., Power, J., Blumbergs, P., & Blessing, W. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79256-4 · Cited by 229
McBride, P. A., Schulz-Schaeffer, W. J., Donaldson, M., Bruce, M., Diringer, H., Kretzschmar, H. A., & Beekes, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9320-9327.2001 · Cited by 228
Self-citationSpine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age
Ingham, C. A., Hood, S. H., & Arbuthnott, G. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)91686-7 · Cited by 219
The Paraffin-Embedded Tissue Blot Detects PrPSc Early in the Incubation Time in Prion Diseases
Schulz-Schaeffer, W. J., Tschöke, S., Kranefuss, N., Dröse, W., Hause-Reitner, D., Giese, A., Groschup, M. H., & Kretzschmar, H. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64705-0 · Cited by 206
Self-citationClinical and quantitative pathologic correlates of dementia with Lewy bodies
Gómez-Tortosa, E., Newell, K., Irizarry, M. C., Albert, M., Growdon, J. H., & Hyman, B. T. (1999) · Neurology · doi:10.1212/wnl.53.6.1284 · Cited by 204
Cell Death or Synaptic Loss in Alzheimer Disease
Terry, R. D. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1118 · Cited by 200
α‐Synuclein produces a long‐lasting increase in neurotransmitter release
Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R. D., & Arancio, O. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600451 · Cited by 198
Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., Xu, S., Liu, C., Gao, Y., Yang, H., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.028 · Cited by 194
Contribution of somal Lewy bodies to neuronal death
Tompkins, M. M., & Hill, W. D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00874-3 · Cited by 183
Evaluation of α-synuclein immunohistochemical methods used by invited experts
Beach, T. G., White, C. L., Hamilton, R. L., Duda, J. E., Iwatsubo, T., Dickson, D. W., Leverenz, J. B., Roncaroli, F., Buttini, M., Hladik, C. L., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0409-8 · Cited by 182 · cited 1×
“Currently the neuropathological diagnosis of Parkinson’s disease and dementia with Lewy bodies is based on the detection and quantification of Lewy bodies [8, 9, 38, 97– 99].”
BackgroundIwatsubo, T., Yamaguchi, H., Fujimuro, M., Yokosawa, H., Ihara, Y., Trojanowski, J. Q., & Lee, V. M. (1996) · Europe PMC (PubMed Central) · Cited by 179
Characterization of Cytoplasmic α-Synuclein Aggregates
Lee, H.-J., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208192200 · Cited by 173
Thirty years of synaptosome research
Whittaker, V. P. (1993) · Journal of Neurocytology · doi:10.1007/bf01181319 · Cited by 173
NAKAJO, S., TSUKADA, K., OMATA, K., NAKAMURA, Y., & NAKAYA, K. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18337.x · Cited by 170
In vivo imaging of synaptic function in the central nervous system
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.008 · Cited by 163
Does α‐synuclein modulate dopaminergic synaptic content and tone at the synapse?
Sidhu, A., Wersinger, C., & Vernier, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-1112rev · Cited by 163
Javoy-Agid, F., Hirsch, É. C., Dumas, S., Duyckaerts, C. J., Mallet, J. J., & Agid, Y. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90389-l · Cited by 146
PrPSc accumulation in myocytes from sheep incubating natural scrapie
Andréoletti, O., Simon, S., Lacroux, C., Morel, N., Tabouret, G., Chabert, A., Lugan, S., Corbière, F., Ferré, P. J., Foucras, G., et al. (2004) · Nature Medicine · doi:10.1038/nm1055 · Cited by 140
Al-Wandi, A., Ninkina, N., Millership, S., Williamson, S. J. M., Jones, P. A., & Buchman, V. L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.001 · Cited by 129
Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies
Gómez-Isla, T., Growdon, W. B., McNamara, M., Newell, K., Gómez-Tortosa, E., Hedley-Whyte, E. T., & Hyman, B. T. (1999) · Neurology · doi:10.1212/wnl.53.9.2003 · Cited by 122
Aoki, C., Sekino, Y., Hanamura, K., Fujisawa, S., Mahadomrongkul, V., Ren, Y., & Shirao, T. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20449 · Cited by 120
Weisman, D., & McKeith, I. G. (2007) · Seminars in Neurology · doi:10.1055/s-2006-956754 · Cited by 120
Prions in Milk from Ewes Incubating Natural Scrapie
Lacroux, C., Simon, S., Benestad, S. L., Maillet, S., Mathey, J., Lugan, S., Corbière, F., Cassard, H., Costes, P., Bergonier, D., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000238 · Cited by 118
Hornykiewicz, O. (2008) · Neurodegenerative Diseases · doi:10.1159/000113678 · Cited by 103
In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution
Weisman, D., Cho, M., Taylor, C., Adame, A., Thal, L. J., & Hansen, L. A. (2007) · Neurology · doi:10.1212/01.wnl.0000266626.64913.0f · Cited by 101
Nakajo, S., Shioda, S., Nakai, Y., & Nakaya, K. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90187-2 · Cited by 100
Peripheral Nervous System-specific Genes Identified by Subtractive cDNA Cloning
Akopian, A. N., & Wood, J. N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21264 · Cited by 100
Polyvinylpyrrolidone as a blocking agent in immunochemical studies
Haycock, J. W. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1068 · Cited by 97
Sporadic Creutzfeldt–Jakob disease: Clinical and diagnostic characteristics of the rare VV1 type
Meißner, B., Westner, I. M., Kallenberg, K., Krasnianski, A., Bartl, M., Varges, D., Bösenberg, C., Kretzschmar, H. A., Knauth, M., Schulz‐Schaeffer, W., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000184674.32924.c9 · Cited by 97
Self-citationSolis, O., Limón, D. I., Flores‐Hernández, J., & Flores, G. (2007) · Synapse · doi:10.1002/syn.20381 · Cited by 93
Subcellular localisation of recombinant α- and γ-synuclein
Specht, C. G., Tigaret, C. M., Rast, G. F., Thalhammer, A., Rudhard, Y., & Schoepfer, R. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.09.017 · Cited by 90
Thomzig, A., Spassov, S. G., Friedrich, M., Naumann, D., & Beekes, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403730200 · Cited by 87
α‐Synuclein–synaptosomal membrane interactions
Jo, E., Darabie, A. A., Han, K. A., Tandon, A., Fraser, P. E., & McLaurin, J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04250.x · Cited by 83
Scheibel, M. E., & Scheibel, A. B. (1978) · Elsevier eBooks · doi:10.1016/b978-0-12-590350-9.50011-2 · Cited by 82
Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie‐infected mice
Belichenko, P. V., Brown, D., Jeffrey, M., & Fraser, J. R. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.026002143.x · Cited by 80
Naoi, M., Maruyama, W., Yi, H., Inaba, K., Akao, Y., & Shamoto‐Nagai, M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0309-7 · Cited by 74
Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
Patt, S., Gertz, H., Gerhard, L., & Cervós‐Navarro, J. (1991) · PubMed · Cited by 73
Bouzamondo, E., Hopkins, S. D., Spilman, P., Uyehara‐Lock, J. H., Deering, C., Safar, J., Prusiner, S. B., Ralston, H. J., & DeArmond, S. J. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.8.882 · Cited by 65
Thomzig, A., Schulz‐Schaeffer, W., Kratzel, C., Mai, J., & Beekes, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21083 · Cited by 63
Self-citationExpression and Subcellular Location of Alpha-Synuclein During Mouse-Embryonic Development
Zhong, S., Luo, X. G., Chen, X.-S., Cai, Q., Liu, J., Chen, X., & Yao, Z. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9473-4 · Cited by 61
Localization of Alpha-synuclein to identified fibers and synapses in the normal mouse brain
Totterdell, S., & Meredith, G. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.047 · Cited by 61
Do neuronal inclusions kill the cell?
Terry, R. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_12 · Cited by 60
Clinical and Neuropathological Correlates of Dementia with Lewy Bodies
GÓMEZ‐TORTOSA, E., IRIZARRY, M. C., GÓMEZ‐ISLA, T., & HYMAN, B. T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06899.x · Cited by 59
Thomzig, A., Schulz‐Schaeffer, W., Wrede, A., Wemheuer, W., Brenig, B., Kratzel, C., Lemmer, K., & Beekes, M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030066 · Cited by 57
Self-citationDeutch, A. Y. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_12 · Cited by 55
Neuroanatomical research techniques
(1980) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(80)90279-5 · Cited by 55
Thomzig, A., Schulz‐Schaeffer, W., Kratzel, C., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421083 · Cited by 54
Self-citationLangston, J. W., Sastry, S., Chan, P., Forno, L. S., Bolin, L. M., & Monte, D. A. D. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6975 · Cited by 50
Ritchie, D. L., Head, M. W., & Ironside, J. W. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2003.00544.x · Cited by 48
Patterns of cell death triggered in two different cell lines by HypF‐N prefibrillar aggregates
Bucciantini, M., Rigacci, S., Berti, A., Pieri, L., Cecchi, C., Nosi, D., Formigli, L., Chiti, F., & Stefani, M. (2004) · The FASEB Journal · doi:10.1096/fj.04-3086fje · Cited by 47
Gubellini, P., Picconi, B., Filippo, M. D., & Calabresi, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.001 · Cited by 45
Wemheuer, W. M., Benestad, S. L., Wrede, A., Schulze‐Sturm, U., Wemheuer, W., Hahmann, U., Gawinecka, J., Schütz, E., Zerr, I., Brenig, B., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090623 · Cited by 45
Self-citationDrebrin a content correlates with spine head size in the adult mouse cerebral cortex
Kobayashi, C., Aoki, C., Kojima, N., Yamazaki, H., & Shirao, T. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21408 · Cited by 43
Detection of PrPSc in subclinical BSE with the paraffin-embedded tissue (PET) blot
Schulz‐Schaeffer, W., Fatzer, R., Vandevelde, M., & Kretzschmar, H. A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6308-5_16 · Cited by 43
Self-citationWinklhofer, K. F., Hartl, F. U., & Tatzelt, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02692-8 · Cited by 41
PET-blot Analysis Contributes to BSE Strain Recognition in C57Bl/6 Mice
Lezmi, S., Bencsik, A. A., & Baron, T. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6892.2006 · Cited by 41
Alpha-synuclein: between synaptic function and dysfunction.
Rosa, G. D., Puzzo, D., Sant'Angelo, A., Trinchese, F., & Arancio, O. (2003) · PubMed · doi:10.14670/hh-18.1257 · Cited by 39
Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies
Zaja-Milatovic, S., Keene, C. D., Montine, K. S., Leverenz, J. B., Tsuang, D., & Montine, T. J. (2006) · Neurology · doi:10.1212/01.wnl.0000216137.09685.c1 · Cited by 35
Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies
Revuelta, G. J., Rosso, A., & Lippa, C. F. (2008) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317507310565 · Cited by 35
McKeith, I. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84060-7 · Cited by 34
Golgi'S Dichromate-Silver Method 3. Chromating Fluids
Davenport, H. A., & Combs, C. M. (1954) · Stain Technology · doi:10.3109/10520295409115463 · Cited by 29
Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release
Hardy, J., Dodd, P. R., Oakley, A. E., Kidd, A. M., Perry, R. H., & Edwardson, J. A. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90392-5 · Cited by 27
Linazasoro, G. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01853.x · Cited by 25
Parkinson's disease dementia – A diminished role for the Lewy body
Libow, L. S., Frisina, P. G., Haroutunian, V. H., Perl, D. P., & Purohit, D. P. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.003 · Cited by 24
Kramer, M. L., Behrens, C., & Schulz‐Schaeffer, W. (2008) · BioTechniques · doi:10.2144/000112691 · Cited by 24
Self-citationAoki, C., Mahadomrongkul, V., Fujisawa, S., Habersat, R., & Shirao, T. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21485 · Cited by 21
Altered neurofilament expression does not contribute to Lewy body formation.
Bergeron, C., Petrunka, C. N., Weyer, L., & Pollanen, M. S. (1996) · Europe PMC (PubMed Central) · Cited by 20
Detection of classical and atypical/Nor98 scrapie by the paraffin‐embedded tissue blot method
Wemheuer, W. M., Benestad, S. L., Wrede, A., Wemheuer, W., Brenig, B., Bratberg, B., & Schulz‐Schaeffer, W. (2009) · Veterinary Record · doi:10.1136/vr.164.22.677 · Cited by 16
Self-citationAltered neurofilament expression does not contribute to Lewy body formation.
Hill, W. (1996) · Europe PMC (PubMed Central) · Cited by 11
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
Lamptey, R. N. L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., & Singh, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031851 · Cited by 900
Metadata
- Authors
- Schulz-Schaeffer, W. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-06-20
- Volume
- 120
- Issue
- 2
- Pages
- 131-143
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2892607
- OpenAlex
- W2033827101
- Cited by
- 627
- References
- 165
- Citations by year
- 2026: 38 · 2025: 51 · 2024: 45 · 2023: 24 · 2022: 43 · 2021: 48 · 2020: 48 · 2019: 41 · 2018: 40 · 2017: 35 · 2016: 36 · 2015: 29 · 2014: 41 · 2013: 36 · 2012: 35
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- GRO (submittedVersion, cc-by)
- Funders
- Volkswagen Foundation (ZN 2168)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein aggregation, Lewy bodies, dementia with Lewy bodies, Parkinson's disease, Parkinson's disease dementia, presynaptic dysfunction, synaptic pathology, neurotransmitter deficiency, neurodegeneration, trans-synaptic spread, stem cell transplantation, synapse regeneration
- MeSH terms
- Animals, Brain, Parkinson Disease, Synapses, Lewy Body Disease, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.